LSBio
KDR / VEGFR2 / FLK1 Antibody (Amino Acid: 20-764, clone 4B4)

VEGF Receptor 2 Antibody in Flow Cytometry (Flow)

KDR / VEGFR2 / FLK1 Antibody (Amino Acid: 20-764, clone 4B4)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Flow Cytometry, Immunocytochemistry, Immunofluorescence, Western Blot
Reactivity:Human
Format:Liquid
See all Human KDR / VEGFR2 / FLK1 antibodies →
$552.00each
Catalog Number: LS-C758794-100

For bulk orders or custom formulations:

Request a Quote

Overview

Description
FLK1 antibody LS-C758794 is an unconjugated mouse monoclonal antibody to human FLK1 (KDR / VEGFR2) (Amino Acid: 20-764). Validated for Flow, ICC, IF and WB.
Application
FC, ICC, IF, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
CD309 | Fetal liver kinase 1 | Fetal liver kinase-1 | KDR | FLK-1 | FLK1 | Kinase insert domain receptor | Quek1 | VEGFR | VEGFR2 | Soluble VEGFR2 | VEGF receptor 2 | VEGFR-2 | CD309 antigen | VEGF-R2
Recommended Dilution: FC
1:200 - 1:400
Recommended Dilution: IF/ICC
1:200 - 1:1000
Recommended Dilution: WB
1:500 - 1:2000
UniProt Number
P35968
SwissProt
P35968

Target

Target
Human KDR / VEGFR2 / FLK1
Antigen Species
Human
Gene Name
KDR

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
4B4
Isotype
IgG1
Origin Species
Human

Immunogen

Immunogen
Purified recombinant extracellular fragment of human KDR (aa20-764) fused with hIgGFc tag expressed in HEK293 cells.
Immunogen Type
Recombinant Protein Fragment

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
Ascites, 0.03% sodium azide
Volume
100 Microliter
Preservative
Yes
Purification Method
Unpurified (Serum / Ascites / Supernatant)

Storage & Handling

Storage Conditions
Short term: 4°C; Long term: -20°C. Avoid freeze-thaw cycles.

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.